Clinical Trials Browser

Phase 1/2 × NETWORK × Pemetrexed × Clear all

NCT00516100 2010-01-15

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung